Mubarak Zubair Abdullahi, Bashir Dagauda Garba, Nafisa Bello, Rabiu Musa, Jamilu Ahmad
F-TPA-SAM2 uses a stable category-conditioned input to select between the two trained anatomical targets. However, matched no-text and random-code controls indicate that pre-trained language semantics are not necessary for this result. The findings do not establish open-vocabulary or multi-anatomy segmentation; clinical utility requires a sonographer-in-the-loop and prospective validation.
BACKGROUND: Congenital anomalies are a major cause of perinatal morbidity and mortality worldwide. Although prenatal ultrasonography is the primary method for detecting structural fetal anomalies, evidence on their prevalence among low-risk pregnancies in Nigeria remains limited. The objective of this study is to determine the sonographic prevalence of congenital fetal anomalies among low-risk pregnant women attending antenatal clinics in Zaria, Northwestern Nigeria.
METHODOLOGY: This hospital-based cross-sectional study was conducted between March and September 2024 among 570 low-risk pregnant women attending Ahmadu Bello University Teaching Hospital, Kofar Gaya General Hospital, and the University Health Services (Sick Bay), Zaria. Participants underwent routine second-trimester fetal anomaly scans following standardized ultrasound protocols. Data were analysed using descriptive statistics, and the prevalence of congenital anomalies was calculated with 95% confidence intervals.
RESULTS: The mean maternal age was 26.0 ± 5.1 years, while the mean gestational age at ultrasound examination was 21.2 ± 2.2 weeks. Eight fetuses were diagnosed with congenital anomalies, giving an overall prevalence of 1.4% (95% CI: 0.6-2.8%). Central nervous system anomalies were the most common abnormalities, followed by cardiac and urogenital anomalies. Some affected fetuses had anomalies involving more than one organ system.
CONCLUSION: Congenital fetal anomalies occur even among pregnancies considered clinically low risk. These findings support routine second-trimester fetal anomaly screening for all pregnant women to facilitate early diagnosis, appropriate counselling, and timely obstetric management.